Study Of Safety, Tolerability And Effects Of PF-05175157 In Adults With Moderate To Severe Acne Vulgaris

Summary

This is a 6 week study to characterize the safety, tolerability and effects of PF-05175157 administered for 6 weeks in subjects with moderate to severe acne vulgaris.

Timeline

Start

2014-04

Primary completion

2014-10

Completion

2014-10

Outcome

Outcome not reported

Stopped: “Study canceled”

Drugs

Indications